Date and Time
January 12, 2024
08:45 – 17:30
Artificial Intelligence is on its best way to become an important tool in medicine including its application in diagnostic steps, but also in clinical everyday work and the generation of scientific data, but also in the development of scientific careers and in publishing. This implies a series of hierarchical steps which not only relate to each of the mentioned topics, but also to ethical issues, legal responsibilities and questions of scientific originality and accuracy. The presentation of all these aspects will be part of the symposium which is – deducting from the close interaction of medical and scientific conduct – closely devoted to legal and ethical issues.
From a legal perspective, the event will provide a complete overview of the relevant European and Austrian legal situation, both from an academic and a practical perspective. The focus of interest is in particular on the AI Act, the AI Liability Directive, the European Health Data Space Act and national requirements of professional law and liability law. The aim is, on the one hand, to provide participants having a medical background with an orientation on regulatory opportunities and risks of AI use in treatment and research. On the other hand, participants with a legal background should be able to grasp which regulatory requirements can (not) beimplemented in a medically meaningful way and which consequences result from this for the legal and ethical AI-related framework of medical professional practice.
Univ. Professor Dr. Dr.h.c. Christoph Zielinski
Director of the Central European Cancer Center at WienerPrivatklinik and president of the Central European CooperativeOncology Group; previously head of the Vienna Cancer Centerand director of the Clinical Division of Oncology and of theDepartment of Medicine, as well as of the Comprehensive CancerCenter at Medical University Vienna and the General Hospital inVienna, Austria; training in immunology, clinical immunology,medicine and medical oncology at the University of Vienna,Austria, and at Tufts University in Boston, Mass., USA; member ofthe European Society for Medical Oncology,
currently serves asCouncil Member and as Editor in Chief of the society’s scientificpeer review journal “ESMO Open – Cancer Horizons”; publishedover 600 original papers and reviews in peer-reviewed journals,and many books. His h-index is 65 and the citations of scientificpapers authored by him exceed 19,000.
Univ. Professor Dr. Nikolaus Forgó
studied law in Vienna and Paris, was an assistant at the Faculty ofLaw of the University of Vienna and its IT officer from 1990 to2000; in 1998, he founded and still heads the University Coursefor Information and Media Law at the University of Vienna,Professor for Legal Informatics and IT Law at the LeibnizUniversity of Hanover from 2000 to 2017, where he was, amongstothers, Head of the Institute for Legal Informatics, DataProtection Officer and CIO. Since 2017 Professor of Technologyand Intellectual Property Law and Director of the Institute forInnovation and Digitalisation in Law at the University of Vienna,since 2018 member of the Austrian Data Protection Council.Extensive teaching, research, consulting and third-party fundingactivities on all issues of IT law, legal informatics and basic legalprinciples, as well as numerous activities in legal education,especially as host of the podcast Ars Boni.
Speaker Highlights and Talk Teasers for AI in Medicine Event
|Registration until October 31, 2023
|Registration after October 31, 2023
1 All registration fees include the applicable VAT. Fees include access to the scientific sessions and refreshments during coffee and lunch breaks.
2 Applies to attendees with a background in academic medicine & academic legal studies including researchers, students, and medical & legal professionals.
3 Applies to attendees with a profit-oriented background, like private healthcare or law practitioners, industry representatives and general attendees.
All attendees will receive an invoice by e-mail when the registration form has been submitted. Payment of registration fees, must be made in EURO through one of the following options:
- Credit Card during online registration: Mastercard, Visa
- Bank Transfer to the symposium organisers’ bank account. Payments need to be made without charges to the beneficiary. Clearly state the registration number, payment order number and delegate’s name when processing the transaction.
Important: The discounted early registration fees are only applicable if the respective fee has also been paid to the conference account before October 31, 2023.
All attendees will receive a written confirmation of registration by e-mail when the registration form has been submitted and the payment has been credited to the conference account.
Cancellations and refunds
Notice of cancellation (e.g. in case of sickness, lack of funding or any other personal reasons) must be made in writing by e-mail to the organisers: email@example.com.
The notification must include all relevant information regarding the bank account to which a possible refund may be remitted. The cancellation will not be effective until a written acknowledgement from the organisers is received. Please note that a refund will only be made to the person acquiring a ticket and not to the named delegate if different from the original buyer.
Registration fees may be refunded if written cancellation if received as follows:
– until October 31, 2023 75% refund
– between October 31-December 31, 2023 25% refund
– as of January 1, 2024 no refund
The date of the email receipt will be the basis for considering refunds. Please indicate your bank details on your written cancellation. Refunds will be made after the conference.
Financial Support & Sponsors
We kindly thank the following sponsors for their support:
Do you want to be part of this exciting event? Make use of our various sponsoring options!
Why you should support the AI in Medicine – Vision – Reality – Legal Aspects Meeting:
- Connect with the participants – representatives of various medical disciplines, legal experts and regulatory bodies
- Get an update on the newest developments and trends in the field
- Take the opportunity for exchange with renowned experts about the challenges and opportunities of AI in the field of medicine
Spread the Word
Inform your colleagues about your participation at this exciting event by sharing the news on Twitter including #medai24.